ARTICLE | Company News
R-Tech Ueno, Sucampo deal
March 16, 2015 7:00 AM UTC
Sucampo returned all rights to unoprostone isopropyl ( UF-021) to R-Tech after the product missed the primary endpoint in a Japanese Phase III trial to treat retinitis pigmentosa (RP). Last year, Suca...